To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 17 Dec 2012
At a glance
- Drugs Ezetimibe/simvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 17 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Jun 2012 Planned End Date changed from 1 Dec 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov.